Epigenetic silencing of MIR342 and its host gene EVL by DNA methylation was reported in colorectal cancer (13, 24, 25), multiple myeloma (26), and B cell lymphoma (27) from the patients. This evidence concerns the gene MIR342 and plasma cell myeloma.